Critical care medicine
-
To investigate whether systemic erythropoietin administration can prevent secondary burn progression in an experimental model and to elucidate the underlying mechanisms. ⋯ Erythropoietin represents an easy-to-use therapeutic approach to prevent secondary burn progression, i.e., to control damage after burn injury. It preserves microcirculatory perfusion within the endangered areas in a dose-dependent manner.
-
Critical care medicine · Apr 2013
Editorial CommentManaging uncertainty in claims-based sepsis research.